Latest News & Updates

Breaking News

  • 13 minutes ago

  • Vaibhavi M.

Telix’s Pixclara NDA Accepted By US FDA, Review Underway For Glioma Imaging Agent With September 2026 Decision Timeline
Breaking News
Glenmark Secures US FDA Approval For Progesterone Vaginal Inserts, Expands Presence In $59.2 Million Market

Vaibhavi M.

Other trending news you may like to read

Telix’s Pixclara NDA Accepted By US FDA, Review Underway For Glioma Imaging Agent With September 2026 Decision Timeline

Telix Pharmaceuticals Limited NDA for Pixclara (TLX101-Px) accepted by FDA for glioma imaging, with PDUFA date set for September 2026 to support brain cancer diagnosis.

Vaibhavi M.

Pharma Now

Glenmark Secures US FDA Approval For Progesterone Vaginal Inserts, Expands Presence In $59.2 Million Market

Glenmark Pharmaceuticals Limited secures FDA approval for progesterone vaginal inserts 100 mg, a generic of Endometrin, to treat infertility-related conditions in women’s health.

Vaibhavi M.

Pharma Now

ANI Pharmaceuticals Launches Generic Isosorbide Mononitrate Tablets For Angina Treatment, Following FDA Approval

ANI Pharmaceuticals launches generic Isosorbide Mononitrate tablets for angina treatment following FDA approval, expanding access to affordable nitrate therapy options.

Vaibhavi M.

Pharma Now

Plus Therapeutics Secures FDA Orphan Drug Designation For REYOBIQ In Pediatric Brain Tumours

Plus Therapeutics gains FDA Orphan Drug Designation for REYOBIQ in pediatric malignant gliomas and ependymoma, advancing targeted radiotherapy for rare brain tumors.

Vaibhavi M.

Pharma Now